Clinical Trial Update: Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic hematopoietic stem cell transplantation with FBM conditioning for myelodysplastic syndrome with excess blasts-1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Allogeneic haematopoietic stem cell transplantation with FBM conditioning

Snippet

Sponsor: Ruijin Hospital | Conditions: Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2 | Phase 2 | Status: UNKNOWN